N of 1 trials. Practical tools for medication management

C. J. Nikles; P. P. Glasziou; C. B. Del Mar; C. M. Duggan; G. Mitchell

N of 1 trials. Practical tools for medication management

C. J. Nikles^*
, P. P. Glasziou
, C. B. Del Mar
, C. M. Duggan
, G. Mitchell

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Research › peer-review

25 Citations (Scopus)

Abstract

BACKGROUND: In single patient (n of 1) trials, a patient acts as his or her own control in a study comparing the effectiveness of a drug with placebo or another drug. The aim of a single patient trial (SPT) is to identify the best treatment for the individual patient, formalising a 'trial of treatment' by using blinding and multiple crossover periods. OBJECTIVE: We have successfully piloted SPTs for osteoarthritis and attention deficit hyperactivity disorder, and several others are currently being piloted. Barriers encountered include: obtaining identical placebos, ethical approval for individual SPTs, standardising doses, determining length of treatment periods, patient withdrawals and cost of the SPTs. DISCUSSION: Only prescribing medications if an individual has been shown to be a responder can greatly benefit general practitioners, patients and the healthcare system. We have established the infrastructure necessary to offer a single patient trial service to GPs and patients anywhere in Australia. This has the potential to revolutionise prescribing for certain chronic conditions.

Original language	English
Pages (from-to)	1108-1112
Number of pages	5
Journal	Australian Family Physician
Volume	29
Issue number	11
Publication status	Published - Nov 2000
Externally published	Yes

Cite this

@article{0db31d432ef041978388760d109a8318,

title = "N of 1 trials. Practical tools for medication management",

abstract = "BACKGROUND: In single patient (n of 1) trials, a patient acts as his or her own control in a study comparing the effectiveness of a drug with placebo or another drug. The aim of a single patient trial (SPT) is to identify the best treatment for the individual patient, formalising a 'trial of treatment' by using blinding and multiple crossover periods. OBJECTIVE: We have successfully piloted SPTs for osteoarthritis and attention deficit hyperactivity disorder, and several others are currently being piloted. Barriers encountered include: obtaining identical placebos, ethical approval for individual SPTs, standardising doses, determining length of treatment periods, patient withdrawals and cost of the SPTs. DISCUSSION: Only prescribing medications if an individual has been shown to be a responder can greatly benefit general practitioners, patients and the healthcare system. We have established the infrastructure necessary to offer a single patient trial service to GPs and patients anywhere in Australia. This has the potential to revolutionise prescribing for certain chronic conditions.",

author = "Nikles, \{C. J.\} and Glasziou, \{P. P.\} and \{Del Mar\}, \{C. B.\} and Duggan, \{C. M.\} and G. Mitchell",

year = "2000",

month = nov,

language = "English",

volume = "29",

pages = "1108--1112",

journal = "Australian Family Physician",

issn = "2208-7958",

publisher = "Royal Australian College of General Practitioners",

number = "11",

}

TY - JOUR

T1 - N of 1 trials. Practical tools for medication management

AU - Nikles, C. J.

AU - Glasziou, P. P.

AU - Del Mar, C. B.

AU - Duggan, C. M.

AU - Mitchell, G.

PY - 2000/11

Y1 - 2000/11

N2 - BACKGROUND: In single patient (n of 1) trials, a patient acts as his or her own control in a study comparing the effectiveness of a drug with placebo or another drug. The aim of a single patient trial (SPT) is to identify the best treatment for the individual patient, formalising a 'trial of treatment' by using blinding and multiple crossover periods. OBJECTIVE: We have successfully piloted SPTs for osteoarthritis and attention deficit hyperactivity disorder, and several others are currently being piloted. Barriers encountered include: obtaining identical placebos, ethical approval for individual SPTs, standardising doses, determining length of treatment periods, patient withdrawals and cost of the SPTs. DISCUSSION: Only prescribing medications if an individual has been shown to be a responder can greatly benefit general practitioners, patients and the healthcare system. We have established the infrastructure necessary to offer a single patient trial service to GPs and patients anywhere in Australia. This has the potential to revolutionise prescribing for certain chronic conditions.

AB - BACKGROUND: In single patient (n of 1) trials, a patient acts as his or her own control in a study comparing the effectiveness of a drug with placebo or another drug. The aim of a single patient trial (SPT) is to identify the best treatment for the individual patient, formalising a 'trial of treatment' by using blinding and multiple crossover periods. OBJECTIVE: We have successfully piloted SPTs for osteoarthritis and attention deficit hyperactivity disorder, and several others are currently being piloted. Barriers encountered include: obtaining identical placebos, ethical approval for individual SPTs, standardising doses, determining length of treatment periods, patient withdrawals and cost of the SPTs. DISCUSSION: Only prescribing medications if an individual has been shown to be a responder can greatly benefit general practitioners, patients and the healthcare system. We have established the infrastructure necessary to offer a single patient trial service to GPs and patients anywhere in Australia. This has the potential to revolutionise prescribing for certain chronic conditions.

UR - https://www.scopus.com/pages/publications/0034321552

M3 - Review article

C2 - 2000142482

AN - SCOPUS:0034321552

SN - 2208-7958

VL - 29

SP - 1108

EP - 1112

JO - Australian Family Physician

JF - Australian Family Physician

IS - 11

ER -

N of 1 trials. Practical tools for medication management

Abstract

Other files and links

Fingerprint

Cite this